Innoviz Technologies has received additional time, until March 22, 2027, to meet Nasdaq’s $1.00 minimum bid-price requirement for ordinary shares. The extension leaves its Nasdaq Capital Market listing and trading unchanged immediately, while the company considers a reverse share split if needed to regain compliance.
Key Highlights
- Nasdaq’s September 22, 2026, notification extends Innoviz Technologies’ opportunity to restore compliance through March 22, 2027.
- The company’s initial compliance period ended September 21, 2026, without the ordinary shares reaching Nasdaq’s required bid level.
- Innoviz intends to monitor its closing bid price during the extended compliance period.
The company has until March 22, 2027, to bring its ordinary shares to at least Nasdaq’s $1.00 minimum bid-price requirement after failing to regain compliance during its initial period.
Nasdaq Extends Bid-Price Compliance Window
Nasdaq’s Listing Qualifications Department granted Innoviz (NASDAQ: INVZ) an additional compliance period ending March 22, 2027. The decision followed a March 25, 2026, notice that the closing bid for the ordinary shares had stayed below $1.00 for 30 consecutive Business days. The company intends to monitor its closing bid price during the extended period.
Until compliance is restored, the notification itself does not immediately change the ordinary shares’ Nasdaq listing or trading status.
FAQs
Q: When did Nasdaq notify Innoviz Technologies about the compliance extension?
A: Nasdaq notified Innoviz Technologies on September 22, 2026, that its compliance period runs through March 22, 2027. The extension concerns the $1.00 minimum bid requirement.
Q: How long must Innoviz shares meet Nasdaq’s bid-price threshold?
A: Innoviz’s ordinary shares must regain compliance with Nasdaq’s $1.00 minimum bid-price requirement by March 22, 2027. The article does not state how many consecutive business days the shares must meet the threshold.
Q: What action is Innoviz considering to regain Nasdaq compliance?
A: The article does not state any specific action Innoviz is considering to regain Nasdaq compliance. It states only that the company intends to monitor its closing bid price during the extended period.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.